Our research
What the evidence supports, and where it stops
Most of this industry markets mechanism as though it were outcome. We grade every treatment we offer by the tier of evidence behind it and publish the grade on the page.
Our research is shaping what comes next
Most peptide care focuses on doing more. We study what happens when the goal is finding the right amount. With a fully in-house care team, longevity researchers and 17 protocols graded by evidence tier, we're built to support the bigger picture of your health.
- One of the first longevity-focused programmes studying GLP-1 microdosing
- PhD-led research team behind 11 longevity studies and 9 peer-reviewed publications
- Fully in-house medical team with 199+ years of combined clinical experience
Evidence tiers
How we grade what we offer
The single most useful question about any peptide is not whether it works, but which tier the evidence sits in — and whether you're comfortable with that.
FDA-approved
Full clinical trials, outcome data and a characterised safety profile. The evidence question is settled; the question is whether it's right for you.
Prescribed off-label
An FDA-approved drug used for an indication outside its label, supported by published human research. Legal, common, and something we state explicitly.
Compounded
Prepared by a licensed compounding pharmacy for an individual patient. Not FDA-approved as products. Evidence ranges from strong to preclinical depending on the molecule.
Several research peptides we offer — BPC-157 and TB-500 among them — have encouraging animal data and very limited controlled human evidence. Using them is a considered bet, and we describe it that way rather than dressing it up as established medicine. Read the full explanation.
Product science
What happens before it ships
Licensed pharmacies only
Every prescription is filled by a state-licensed compounding pharmacy or 503B outsourcing facility. Never a research-chemical supplier.
Potency testing
Third-party assay on every lot, confirming the vial contains what the label says within tolerance.
Sterility testing
Every injectable lot is tested for sterility and endotoxin before release.
Certificates on request
Give us the lot number on your vial and we'll send the certificate of analysis for that batch.
Reading
From the research team
Science
NAD+: what the evidence actually supports
An honest read on one of the most hyped compounds in longevity — where the mechanistic case is strong and where the human data runs out.
Science
Peptides, explained without the hype
What a peptide actually is, why this category exploded, and how to tell the well-studied compounds from the ones riding the wave.
Guides
How to read a study before you believe a headline
Six questions that will resolve most longevity claims in under five minutes, without a science degree.
Who decides
The people setting the bar
Dr. Naomi Whitfield, MD, MPH
Chief Medical Officer
Board-certified in internal medicine with a decade in academic geriatrics before moving to telehealth. Sets the clinical protocols and personally reviews every escalation.
Dr. Arun Bhattacharya, PhD
Head of Research
Trained in molecular biology of aging, with published work on mitochondrial function and NAD+ metabolism. Decides which compounds clear our evidence bar — and which don't.
Dr. Elise Moreau, DO
Director of Women's Health
Fifteen years in OB-GYN with a focus on the perimenopausal transition. Built our hormone intake around symptom trajectory rather than a single lab value.
Ready when you are
How you age is up to you
Ten minutes of questions, a licensed clinician's review, and a protocol built for your labs — not an average.